Blog / Archives
Valuation Models for Biopharmaceutical Stocks
Are Biotech Valuations in the "Bubblet" Phase? In September of 2013 we wrote about the valuations of biotechnology companies from an M&A perspective after the acquisition of Onyx Pharmaceuticals...
Risk is Rising-Caution in Biopharmaceutical Stocks
Our Indicators Flash a Caution Signal Today No Change in Portfolio Picks If you are not at 10% cash in your biotechnology portfolio it is time to take profits or hedge your portfolio. If your...
Market Sell-Off Accelerating As Shut-Down Drags On Update 10/4 CLDX
Life Science Trading Update 10/4/13 NASDAQ up 0.88% at 3809 Is the market expecting Boehner to settle? Green screen today with most market leaders up about 2%: AMGN, BIIB, PCYC, REGN, VPHM....
Rayno Biopharmaceuticals Portfolio YTD Performance and New Highs: PCYC,SGEN,REGN
Biotech Stocks Hit New Highs Unfazed By Shutdown Biopharmaceutical stocks continued their blazing Q3 run today buoyed by assumptions that demand for pharmaceuticals will increase with 55 million new...
Biopharma Stocks Take Another Leg Up: ALXN, CBST, PCYC, REGN
Biotech Stocks Will Not Wait for Congress-Huge Rally Across the Board Analysts and Media are Piling On-Momentum Rules IBB up 1.75% XBI up 1.81% Rayno Biopharmaceuticals stocks are in a new leg up...
Biotechnology IPO Market Continues Run with Foundation Medicine (FMI)
Foundation Medicine (FMI) Soars on IPO-Up 75% Foundation Medicine (FMI $32.30), based in Cambridge MA, went public today at $18 offering 5,888,888 M shares and promptly went up 79% on volume over...
Fidelity Select Biotechnology Fund (FBIOX) Outperforms Biotech ETFs YTD
Life Science Sector at or Near YTD and All Time Highs Fidelity Fund (FBIOX) Outperform ETFs Over the past 3 years we reviewed how ETFs complement a biotechnology investment strategy and compared...
Politics Curb Further Market Gains-Short Term Caution
No matter what your political persuasion you should know that your dysfunctional government may weaken the economy and damage your portfolio. Jim McTague in his Sep 23 Barron's column, The GOP's...
Biotech Trading Notes: AEGR, ARRY, CLVS, REGN, RPRX- Update 1 Market Rallies Post FED
No Taper Rallies Stocks and Bonds-Equities up almost 1% Most sectors and stocks turned bright green after FED announces "No Taper". Biotech stocks are up with IBB up 1%. Drug stocks very strong due...
Kythera (KYTH) Soars on Phase III Fat Drug Update 1
Chin-Up and Out! KYTH traded 2.58M shares today closing near its gap up 25% this morning at $41.95 . There was distribution of stock probably from early investors to funds and retail. The market cap...